Distinct requirements for activation-induced cell surface expression of preformed Fas/CD95 ligand and cytolytic granule markers in T cells

被引:0
|
作者
D Kassahn
U Nachbur
S Conus
O Micheau
P Schneider
H-U Simon
T Brunner
机构
[1] Institute of Pathology,Division of Immunopathology
[2] University of Bern,undefined
[3] Institute of Pharmacology,undefined
[4] University of Bern,undefined
[5] INSERM,undefined
[6] U866,undefined
[7] University of Bourgogne,undefined
[8] Institute of Biochemistry,undefined
[9] University of Lausanne,undefined
来源
关键词
cytotoxic T cells; Fas ligand; cytotoxic granules; degranulation; protein kinases;
D O I
暂无
中图分类号
学科分类号
摘要
Fas (CD95/Apo-1) ligand is a potent inducer of apoptosis and one of the major killing effector mechanisms of cytotoxic T cells. Thus, Fas ligand activity has to be tightly regulated, involving various transcriptional and post-transcriptional processes. For example, preformed Fas ligand is stored in secretory lysosomes of activated T cells, and rapidly released by degranulation upon reactivation. In this study, we analyzed the minimal requirements for activation-induced degranulation of Fas ligand. T cell receptor activation can be mimicked by calcium ionophore and phorbol ester. Unexpectedly, we found that stimulation with phorbol ester alone is sufficient to trigger Fas ligand release, whereas calcium ionophore is neither sufficient nor necessary. The relevance of this process was confirmed in primary CD4+ and CD8+ T cells and NK cells. Although the activation of protein kinase(s) was absolutely required for Fas ligand degranulation, protein kinase C or A were not involved. Previous reports have shown that preformed Fas ligand co-localizes with other markers of cytolytic granules. We found, however, that the activation-induced degranulation of Fas ligand has distinct requirements and involves different mechanisms than those of the granule markers CD63 and CD107a/Lamp-1. We conclude that activation-induced degranulation of Fas ligand in cytotoxic lymphocytes is differently regulated than other classical cytotoxic granule proteins.
引用
收藏
页码:115 / 124
页数:9
相关论文
共 50 条
  • [31] Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia
    De Fanis, U
    Mora, LD
    Romano, C
    Sellitto, A
    Tirelli, A
    Lucivero, G
    HAEMATOLOGICA, 2002, 87 (03) : 325 - 327
  • [32] Modulation of Fas (CD95/APO-1) ligand surface expression and release on tumor cells.
    Salih, H
    Davis, P
    Kosowski, S
    Stetsko, D
    Starling, G
    Aruffo, A
    Kiener, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S14 - S14
  • [33] Estrogen prevents activation-induced apoptosis by downregulation of Fas ligand expression in T cells.
    Min, SY
    Cho, ML
    Choi, JJ
    Park, KS
    Yoon, CH
    Kang, HJ
    Min, DJ
    Kim, WU
    Min, JK
    Hong, YS
    Park, SH
    Hwang, SY
    Lee, JL
    Cho, CS
    Kim, HY
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S204 - S204
  • [34] Tumor cells in basal cell carcinoma (BCC) express fas ligand but not Fas antigen (CD95).
    GutierrezSteil, C
    WroneSmith, T
    Melton, J
    Swanson, J
    Nickoloff, BJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 191 - 191
  • [35] Epstein-Barr virus induces Fas (CD95) in T cells and Fas ligand in B cells leading to T-cell apoptosis
    Tanner, JE
    Alfieri, C
    BLOOD, 1999, 94 (10) : 3439 - 3447
  • [36] FAS AND ACTIVATION-INDUCED FAS LIGAND MEDIATE APOPTOSIS OF T-CELL HYBRIDOMAS - INHIBITION OF FAS LIGAND EXPRESSION BY RETINOIC ACID AND GLUCOCORTICOIDS
    YANG, YL
    MERCEP, M
    WARE, CF
    ASHWELL, JD
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05): : 1673 - 1682
  • [37] Lack of T cell receptor-stimulated CD95 ligand up-regulation protects cutaneous T cell lymphoma cells from Activation-induced cell death (AICD)
    Klemke, C. D.
    Brenner, D.
    Schmidt, M.
    Leverkus, M.
    Krammer, P. H.
    EXPERIMENTAL DERMATOLOGY, 2008, 17 (03) : 274 - 274
  • [38] Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to fas ligand
    Suda, T
    Tanaka, M
    Miwa, K
    Nagata, S
    JOURNAL OF IMMUNOLOGY, 1996, 157 (09): : 3918 - 3924
  • [39] Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes
    Leite-De-Moraes, MC
    Herbelin, A
    Gouarin, C
    Koezuka, Y
    Schneider, E
    Dy, M
    JOURNAL OF IMMUNOLOGY, 2000, 165 (08): : 4367 - 4371
  • [40] Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous allospecific T-cell responses in vivo
    Buonocore, S
    Paulart, F
    Le Moine, A
    Braun, M
    Salmon, I
    Van Meirvenne, S
    Thielemans, K
    Goldman, M
    Flamand, V
    BLOOD, 2003, 101 (04) : 1469 - 1476